Myeloma Investment Fund Invests in KAHR’s Lead Immunotherapy Drug for Multiple Myeloma Treatment
The Myeloma Investment Fund (MIF), the Multiple Myeloma Research Foundation‘s (MMRF) venture philanthropy subsidiary, has invested in KAHR, a clinical-stage biotech company, to explore the
Alpha Tau and MIM Software Are Collaborating On Alpha DaRT Treatment Planning
Jerusalem-based Alpha Tau Medical Ltd. (Nasdaq: DRTS) (“Alpha Tau“), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and MIM Software Inc. (“MIM Software”),
Visit Image Navigation’s Latest Dental Surgical Navigational Systems at MIXiii BioConference in Jerusalem, Nov 9-10, 2022
Image Navigation Ltd., a pioneer in surgical navigation systems, will present their second generation Image Guided Implantology (IGI) system at the Jerusalem Ecosystem Booth at
Immunyx Pharma Part of Global Consortium CanceRNA Developing RNA-based Cancer Vaccine
Immunyx Pharma is member of CanceRNA , a global consortium applying RNA-based therapeutics to successfully unlock anti-cancer immune responses. The consortium is led by Professor
Positive Preliminary Phase 1 Data for Oramed Subsidiary Oravax’s Oral Covid-19 Vaccine
Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced that its
Mirror Biologics, Inc. Closes Out $30M Series A Investment Round with Additional $20M
Mirror Biologics, Inc., a clinical-stage biopharmaceutical company today announced the completion of the final $20 million tranche of its $30 million Series A investment round
Breakthrough RNA-Based Cancer Immunotherapy Being Developed by Global Consortium led by Hadassah Cancer Research Inst
Pharmaceutical company Merck and Hadassah University Hospital in Jerusalem launched CanceRNA, which aims to use messenger-RNA technology to treat cancer. CanceRNA, a global consortium that
Image Navigation To Launch World’s Most Advanced Image Guided Dental Implant Technology
Jerusalem-based Image Navigation Ltd., a pioneer in surgical navigation systems, plans to launch its second generation Image Guided Implantology (IGI) system during the EAO Congress
Positive Top-Line Results from Oramed’s Oral Insulin Drug Phase 2 NASH Trial
Oramed Pharmaceuticals Inc. ( Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, announced today positive
